219 related articles for article (PubMed ID: 31562296)
1. Soluble RAGE attenuates AngII-induced endothelial hyperpermeability by disrupting HMGB1-mediated crosstalk between AT1R and RAGE.
Jeong J; Lee J; Lim J; Cho S; An S; Lee M; Yoon N; Seo M; Lim S; Park S
Exp Mol Med; 2019 Sep; 51(9):1-15. PubMed ID: 31562296
[TBL] [Abstract][Full Text] [Related]
2. Soluble RAGE attenuates Ang II-induced arterial calcification via inhibiting AT1R-HMGB1-RAGE axis.
Jeong J; Cho S; Seo M; Lee BS; Jang Y; Lim S; Park S
Atherosclerosis; 2022 Apr; 346():53-62. PubMed ID: 35278873
[TBL] [Abstract][Full Text] [Related]
3. Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability.
Zhou X; Weng J; Xu J; Xu Q; Wang W; Zhang W; Huang Q; Guo X
Cell Physiol Biochem; 2018; 45(4):1717-1730. PubMed ID: 29490301
[TBL] [Abstract][Full Text] [Related]
4. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.
Lee D; Lee KH; Park H; Kim SH; Jin T; Cho S; Chung JH; Lim S; Park S
PLoS One; 2013; 8(8):e69669. PubMed ID: 23936343
[TBL] [Abstract][Full Text] [Related]
5. sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.
Lim S; Lee ME; Jeong J; Lee J; Cho S; Seo M; Park S
Inflamm Res; 2018 Aug; 67(8):691-701. PubMed ID: 29796842
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways.
Huang W; Liu Y; Li L; Zhang R; Liu W; Wu J; Mao E; Tang Y
Inflammation; 2012 Feb; 35(1):350-62. PubMed ID: 21494799
[TBL] [Abstract][Full Text] [Related]
7. Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell.
Zhao MJ; Jiang HR; Sun JW; Wang ZA; Hu B; Zhu CR; Yin XH; Chen MM; Ma XC; Zhao WD; Luan ZG
Front Immunol; 2021; 12():697071. PubMed ID: 34745088
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of soluble RAGE in disturbed flow-induced atherogenesis.
Ha CH; Kim S; Chung J; An SH; Park S; Choi D; Kwon K
Int J Mol Med; 2013 Aug; 32(2):373-80. PubMed ID: 23708564
[TBL] [Abstract][Full Text] [Related]
9. Activating transcription factor 3 SUMOylation is involved in angiotensin II-induced endothelial cell inflammation and dysfunction.
Zhang ZB; Ruan CC; Chen DR; Zhang K; Yan C; Gao PJ
J Mol Cell Cardiol; 2016 Mar; 92():149-57. PubMed ID: 26850942
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis.
Liu M; Yu Y; Jiang H; Zhang L; Zhang PP; Yu P; Jia JG; Chen RZ; Zou YZ; Ge JB
Acta Pharmacol Sin; 2013 Jun; 34(6):830-6. PubMed ID: 23564080
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway.
Huang W; Zhao H; Dong H; Wu Y; Yao L; Zou F; Cai S
Int J Mol Med; 2016 May; 37(5):1189-98. PubMed ID: 27035254
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption.
Wolfson RK; Chiang ET; Garcia JG
Microvasc Res; 2011 Mar; 81(2):189-97. PubMed ID: 21146549
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.
Nakamura K; Yamagishi S; Nakamura Y; Takenaka K; Matsui T; Jinnouchi Y; Imaizumi T
Microvasc Res; 2005 Nov; 70(3):137-41. PubMed ID: 16271939
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II increases the permeability and PV-1 expression of endothelial cells.
Bodor C; Nagy JP; Végh B; Németh A; Jenei A; MirzaHosseini S; Sebe A; Rosivall L
Am J Physiol Cell Physiol; 2012 Jan; 302(1):C267-76. PubMed ID: 22012329
[TBL] [Abstract][Full Text] [Related]
15. Role of Src in Vascular Hyperpermeability Induced by Advanced Glycation End Products.
Zhang W; Xu Q; Wu J; Zhou X; Weng J; Xu J; Wang W; Huang Q; Guo X
Sci Rep; 2015 Sep; 5():14090. PubMed ID: 26381822
[TBL] [Abstract][Full Text] [Related]
16. HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary Tuberculosis.
Lui G; Wong CK; Ip M; Chu YJ; Yung IM; Cheung CS; Zheng L; Lam JS; Wong KT; Sin WW; Choi KW; Lee N
PLoS One; 2016; 11(7):e0159132. PubMed ID: 27434276
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells.
Yang HY; Bian YF; Zhang HP; Gao F; Xiao CS; Liang B; Li J; Zhang NN; Yang ZM
Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1004-10. PubMed ID: 23030315
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation.
Jia C; Zhang J; Chen H; Zhuge Y; Chen H; Qian F; Zhou K; Niu C; Wang F; Qiu H; Wang Z; Xiao J; Rong X; Chu M
Cell Death Dis; 2019 Oct; 10(10):778. PubMed ID: 31611559
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 contributes to the irradiation-induced endothelial barrier injury through receptor for advanced glycation endproducts (RAGE).
Zhou H; Jin C; Cui L; Xing H; Liu J; Liao W; Liao H; Yu Y
J Cell Physiol; 2018 Sep; 233(9):6714-6721. PubMed ID: 29215715
[TBL] [Abstract][Full Text] [Related]
20. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II.
Rius C; Piqueras L; González-Navarro H; Albertos F; Company C; López-Ginés C; Ludwig A; Blanes JI; Morcillo EJ; Sanz MJ
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):96-104. PubMed ID: 23117657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
